Company intelligence / Profile preview

ScitoVation

Durham, North Carolina, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

ScitoVation is a contract research organization using non-animal, human‑relevant in vitro and in silico methods to assess safety and efficacy of pharmaceuticals, food ingredients, agricultural and commodity chemicals, and consumer products; it does not develop its own therapeutic pipeline but supports others’ R&D and regulatory submissions[1][2][3][5].

Modalities: Non-pharmacological therapy
Industry: Contract Research Organization

Partnerships

Integral Consulting (strategic partnership to develop faster chemical safety decisions using advanced molecular and computational toxicology tools)[6]

Beyond the preview

Go deeper on ScitoVation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ScitoVation.

Explore the full profile